Diagnostic Formulation — Formulate diagnoses using current...

SECTION 1

Historical Context & Motivation

The practice of classifying mental disorders has a long and evolving history, shaped by cultural beliefs, scientific advances, and the pragmatic need for a shared professional language. Early attempts at psychiatric classification were largely descriptive and idiosyncratic, with individual clinicians using personal frameworks that made communication across institutions nearly impossible. The emergence of formal diagnostic taxonomies — systematic classification systems for mental health conditions — transformed the field by providing standardized criteria that clinicians, researchers, and insurers could use in common. Understanding the historical arc of diagnostic classification is essential for appreciating both the power and the limitations of modern diagnostic formulation.

1952

DSM-I Published

The American Psychiatric Association publishes the first Diagnostic and Statistical Manual of Mental Disorders, containing 106 disorders heavily influenced by psychodynamic theory and Adolf Meyer's concept of "reactions" to biological, social, and psychological stressors.

1968

DSM-II Published

The DSM-II retained the psychodynamic orientation of its predecessor but expanded to 182 disorders. It is historically significant for listing homosexuality as a mental disorder — a designation that generated intense professional debate and was ultimately removed through an APA membership vote in 1973, marking a watershed moment in the relationship between psychiatric classification, social values, and scientific evidence.

1980

DSM-III: The Atheoretical Revolution

The DSM-III, led by Robert Spitzer, introduced explicit diagnostic criteria, a multiaxial system, and an atheoretical, descriptive approach. This edition dramatically improved diagnostic reliability and became the international gold standard for psychiatric research.

1990

ICD-10 Mental and Behavioral Disorders

The World Health Organization released Chapter V of the ICD-10, providing a global classification system for mental disorders. This system is mandated for mortality and morbidity reporting across WHO member states and emphasized cross-cultural applicability.

1994 / 2000

DSM-IV and DSM-IV-TR

The DSM-IV refined the multiaxial system (Axes I–V) and placed stronger emphasis on empirical evidence for each diagnostic category. Its Text Revision (DSM-IV-TR, 2000) updated supporting text without altering diagnostic criteria. Many practicing clinicians trained under this edition, and its five-axis framework — including the Global Assessment of Functioning (GAF) scale on Axis V — remains familiar to a substantial portion of the current clinical workforce.

2013

DSM-5: Dimensional Approaches Emerge

The DSM-5 eliminated the multiaxial system, introduced dimensional assessments (e.g., severity specifiers, cross-cutting symptom measures), reorganized chapters based on developmental and etiological factors, and incorporated a lifespan developmental perspective.

2022

DSM-5-TR and ICD-11

The DSM-5-TR (Text Revision) updated diagnostic criteria for several disorders including prolonged grief disorder, while the ICD-11 went fully live, featuring dimensional components, complex PTSD, and gaming disorder as new additions. Both systems increasingly converge toward shared frameworks.

The central question that diagnostic formulation addresses is deceptively simple: How do we translate the rich complexity of a client's presenting problems into a reliable, valid, and clinically useful diagnosis? This question demands not only knowledge of current taxonomies but also the clinical judgment to apply criteria accurately, rule out differential diagnoses, account for cultural context, and integrate multiple sources of information into a coherent diagnostic picture.

SECTION 2

Core Principles of Diagnostic Formulation

Diagnostic formulation is more than simply matching symptoms to criteria — it is a structured clinical reasoning process that synthesizes data from interviews, psychological testing, behavioral observations, collateral reports, and medical records into a coherent diagnostic picture. Effective diagnostic formulation rests on several foundational principles that guide clinicians from initial assessment through differential diagnosis and final diagnostic determination.

Criterion-Based Reasoning

Modern taxonomies (DSM-5-TR, ICD-11) use operationalized diagnostic criteria — specific symptom counts, duration thresholds, and functional impairment requirements. Diagnoses are assigned only when full criteria are met, not on the basis of clinical impression alone.

Differential Diagnosis

Clinicians must systematically consider and rule out alternative explanations for a client's symptoms. This involves evaluating whether symptoms are better accounted for by another mental disorder, a medical condition, substance use, or normal developmental variation.

Cultural Formulation

The DSM-5-TR Cultural Formulation Interview (CFI) and the ICD-11's cultural guidance require clinicians to evaluate how cultural identity, idioms of distress, and social determinants of health influence symptom presentation and the meaning attributed to distress.

Dimensional & Categorical Integration

Contemporary practice recognizes that many disorders exist on a spectrum. While diagnoses remain categorical (present/absent), severity specifiers, cross-cutting measures, and dimensional models (e.g., the Alternative Model for Personality Disorders) capture clinical nuance.

Comorbidity Awareness

Psychiatric comorbidity is the rule rather than the exception. Clinicians must determine whether multiple diagnoses are warranted (true comorbidity), whether one condition subsumes another, or whether apparent comorbidity reflects limitations of the categorical system.

✦ KEY TAKEAWAY

Think of diagnostic formulation like a detective constructing a case: you gather evidence from multiple sources, test hypotheses against established criteria, rule out alternative explanations, and arrive at the most parsimonious account that explains the full clinical picture. Just as a detective doesn't arrest someone based on a single clue, a clinician doesn't diagnose based on a single symptom — the convergence of evidence across sources and over time is what makes a diagnosis reliable.

SECTION 3

The Diagnostic Formulation Process: A Visual Overview

The diagnostic formulation process follows a systematic sequence from data gathering through final diagnosis. The following diagram illustrates how clinicians move through this process, integrating multiple sources of information and iteratively refining their diagnostic hypotheses.

This diagram illustrates the seven-step diagnostic formulation workflow (top row and second row), showing how clinicians move from initial data gathering through symptom identification, criterion matching, differential diagnosis, cultural formulation, severity/specifier assignment, and final diagnostic determination. The lower panel displays the six primary data sources that feed into this process at every stage.

As the diagram illustrates, diagnostic formulation is not a linear checklist but an iterative process. A clinician may return to earlier steps — gathering additional data or reconsidering symptom patterns — as new information emerges. The cultural formulation stage, for example, may prompt reconsideration of whether certain symptoms represent pathology or culturally normative expressions of distress. Similarly, the differential diagnosis step often requires revisiting the clinical interview to obtain targeted follow-up information. The data sources shown in the lower panel continuously inform and refine each stage of the process, reinforcing the principle that good diagnostic formulation requires convergent evidence from multiple domains.

SECTION 4

How Diagnostic Taxonomies Work: DSM-5-TR and ICD-11 Structures

Understanding the organizational logic of the DSM-5-TR and ICD-11 is essential for effective diagnostic formulation. Both systems have evolved from purely categorical approaches toward hybrid models that incorporate dimensional elements, yet they differ in structure, scope, and intended use. The DSM-5-TR is primarily used in North America for clinical, research, and administrative purposes, while the ICD-11 serves as the global standard mandated by the World Health Organization for international health statistics and clinical documentation.

DSM-5-TR: Organizational Structure

The DSM-5-TR organizes disorders into 22 diagnostic chapters arranged along a developmental and internalizing–externalizing spectrum. Each disorder entry contains several standardized components: diagnostic criteria (the operationalized symptom sets required for diagnosis), specifiers and subtypes (qualifiers that provide additional clinical detail such as severity, course, or features), diagnostic features (narrative descriptions of the clinical presentation), and differential diagnosis guidance (discussing how to distinguish the disorder from similar conditions). Additionally, the DSM-5-TR includes associated features supporting the diagnosis, prevalence data, development and course information, risk and prognostic factors, culture-related diagnostic issues, sex- and gender-related diagnostic issues, functional consequences, and comorbidity patterns.

ICD-11: Parallel Structure and Key Differences

The ICD-11 Chapter 06 (Mental, Behavioural, or Neurodevelopmental Disorders) uses a similar but distinct organizational framework. A critical structural difference is that the ICD-11 provides Clinical Descriptions and Diagnostic Requirements (CDDR) rather than the rigid polythetic criteria sets of the DSM-5-TR. The CDDR approach uses "essential features" — descriptions of what is necessary for diagnosis — alongside "boundary with normality" and "boundary with other disorders" sections, providing more flexible clinical guidance that may be especially useful in international and primary-care settings where strict criterion counting can be impractical.

Key structural differences between the DSM-5-TR and ICD-11 diagnostic systems

Feature	DSM-5-TR	ICD-11
Publisher	American Psychiatric Association	World Health Organization
Primary Use	Clinical, research, insurance in North America	Global health statistics, international clinical use
Criteria Format	Polythetic criteria sets (e.g., 5 of 9 symptoms)	Essential features with clinical descriptions (CDDR)
Dimensional Elements	Severity specifiers, cross-cutting measures, AMPD (Section III)	Dimensional trait model for personality disorders, severity qualifiers
Personality Disorders	Categorical (Section II) + Alternative Model (Section III)	Fully dimensional: severity + trait domain qualifiers
Notable Unique Diagnoses	Prolonged Grief Disorder, Unspecified/Other Specified categories	Complex PTSD, Gaming Disorder, Bodily Distress Disorder

📋 Clinical Practice Note

In the United States, clinicians typically formulate diagnoses using DSM-5-TR criteria but must code using ICD-10-CM codes (the U.S. clinical modification of the ICD-10) for billing and insurance purposes. The DSM-5-TR includes corresponding ICD-10-CM codes for each disorder. As the ICD-11 is adopted in the U.S., familiarity with both systems becomes increasingly critical for the practicing clinician.

SECTION 5

Differential Diagnosis: The Decision Tree Approach

The differential diagnosis process is arguably the most intellectually demanding aspect of diagnostic formulation. It requires clinicians to systematically evaluate whether a client's symptoms are best explained by one disorder versus another, a general medical condition, substance effects, or normative variation. The DSM-5-TR provides differential diagnosis discussion sections for each disorder, and standardized decision trees guide clinicians through logical branching points. The hierarchical exclusion process typically follows a predictable sequence: first rule out substance-induced or medication-induced presentations, then rule out conditions due to another medical condition, then distinguish among primary mental disorders.

This decision tree demonstrates the hierarchical exclusion process for a client presenting with depressed mood. The clinician proceeds through branching questions — first ruling out substance-induced and medically-caused presentations, then distinguishing between bipolar and unipolar conditions, and finally determining whether full criteria for Major Depressive Disorder are met versus a milder or more chronic condition.

The decision tree approach illustrated above reveals several critical principles for the EPPP. First, substance-related and medical etiologies must always be excluded before assigning a primary mental disorder diagnosis. This is not merely academic — failing to identify a hypothyroid-induced depressive presentation or an alcohol-induced mood disorder can lead to inappropriate treatment. Second, the tree demonstrates the importance of polarity assessment: any history of manic or hypomanic episodes shifts the diagnosis from the depressive disorders chapter to the bipolar disorders chapter, fundamentally changing treatment planning. Third, when two diagnoses share overlapping symptoms, the clinician must apply the DSM-5-TR's "better explained by" rule — assigning the diagnosis that most parsimoniously accounts for the complete symptom picture.

SECTION 6

Worked Example: Formulating a Diagnosis

The following worked example walks through the diagnostic formulation process for a clinical case, demonstrating how clinicians systematically integrate assessment data with taxonomic criteria to arrive at a well-supported diagnosis. This section models the applied skill of formulation as assessed on the EPPP Part 2: how to document clinical reasoning, defend diagnostic conclusions with reference to specific criteria, and connect the formulation to treatment planning.

📄 Clinical Vignette

Maria, a 28-year-old Latina woman, presents for outpatient evaluation following referral from her primary care physician. She reports persistent sadness, loss of interest in activities she previously enjoyed, insomnia (difficulty staying asleep), fatigue, difficulty concentrating at work, feelings of worthlessness, and recurrent thoughts that her family would be better off without her — though she denies any plan or intent to harm herself. Symptoms began approximately 3 months ago following the end of a long-term relationship. She denies substance use, and recent medical labs (TSH, CBC, metabolic panel) are within normal limits. She reports similar episodes at ages 19 and 24, each lasting 3−4 months. She describes feeling nervous and on edge much of the time but identifies this as secondary to her mood. Cultural Formulation Interview reveals she views her distress through a lens of familismo and feels shame about burdening her family.

Diagnostic Formulation for Maria

Step 1 — Gather and Organize Clinical DataThe clinician organizes data from the clinical interview, PCP referral, and medical labs. Key data include: presenting symptoms (sadness, anhedonia, insomnia, fatigue, concentration difficulties, worthlessness, passive suicidal ideation), onset (3 months ago, post-breakup), prior history (two similar episodes), substance use (denied), medical rule-out (labs normal), and cultural context (familismo, shame about distress).

Seven potential depressive symptoms identified; duration ≥ 2 weeks; medical and substance causes ruled out.

Step 2 — Match Symptoms to DSM-5-TR CriteriaThe clinician evaluates against Criterion A for Major Depressive Disorder (MDD): five or more of nine symptoms during the same 2-week period, with at least one being (1) depressed mood or (2) loss of interest/pleasure. Maria endorses: (1) depressed mood — YES, (2) anhedonia — YES, (3) weight/appetite change — not reported, (4) insomnia — YES, (5) psychomotor change — not reported, (6) fatigue — YES, (7) worthlessness/guilt — YES, (8) concentration difficulty — YES, (9) suicidal ideation — YES (passive). Total: 7 of 9 Criterion A symptoms met, including both gating symptoms.

Criterion A met (7/9 symptoms, ≥ 5 threshold, including depressed mood and anhedonia).

Step 3 — Evaluate Remaining Criteria (B through E)Criterion B: Symptoms cause clinically significant distress and impairment in occupational functioning (difficulty concentrating at work) — MET. Criterion C: Episode not attributable to physiological effects of a substance or another medical condition (labs normal, no substance use) — MET. Criterion D: Episode not better explained by a psychotic disorder — no psychotic features reported — MET. Criterion E: There has never been a manic or hypomanic episode — careful history confirms no elevated mood, grandiosity, decreased need for sleep, or flight of ideas — MET.

All supplementary criteria (B–E) satisfied. Preliminary diagnosis: Major Depressive Disorder.

Step 4 — Differential DiagnosisThe clinician considers: (a) Bipolar II Disorder — ruled out, no hypomanic history; (b) Persistent Depressive Disorder — ruled out as primary, though double depression should be assessed given recurrent episodes; (c) Adjustment Disorder with Depressed Mood — ruled out because full MDD criteria are met (adjustment disorder requires subthreshold presentation); (d) Generalized Anxiety Disorder — anxiety symptoms are present but described as secondary to mood state; clinician notes potential comorbid GAD requiring further assessment; (e) Normal bereavement/grief — while the breakup is a stressor, the severity, duration, and suicidal ideation exceed normative grief reactions.

MDD is the most parsimonious diagnosis; rule out comorbid GAD with additional assessment.

Step 5 — Assign Specifiers and Cultural FormulationBased on the full clinical picture, the clinician assigns specifiers: Recurrent episode (third lifetime episode), Moderate severity (multiple symptoms beyond minimum, moderate functional impairment but still maintaining employment), With anxious distress (nervous, on edge). Cultural formulation: Maria's familismo values shape her help-seeking behavior and contribute to feelings of worthlessness; her shame about burdening family members should be incorporated into treatment planning. The WHO Disability Assessment Schedule (WHODAS 2.0) score of 32 confirms moderate disability.

Final Diagnosis: Major Depressive Disorder, Recurrent, Moderate, With Anxious Distress (F33.1)

Step 6 — Connect Formulation to Documentation and Treatment PlanningThe diagnostic formulation directly informs treatment planning — a critical competency assessed on the EPPP Part 2. For Maria, the MDD diagnosis with anxious distress specifier supports a combination of cognitive-behavioral therapy (CBT) and consideration of antidepressant pharmacotherapy in consultation with her PCP. The recurrent episode course indicates monitoring for future episodes and possible maintenance treatment. The cultural formulation findings — familismo values and shame-based help-seeking — guide the clinician to frame treatment collaboratively, involve family psychoeducation if Maria consents, and address shame as a therapeutic target. The passive suicidal ideation requires ongoing safety monitoring documented in the clinical record. When documenting this formulation for supervision, peer review, or legal purposes, the clinician should explicitly connect each diagnostic conclusion to the supporting evidence: 'MDD, Recurrent, Moderate is supported by the presence of 7 of 9 Criterion A symptoms, confirmed absence of manic history, and normal medical workup. The anxious distress specifier is warranted by endorsement of feeling keyed up and on edge on most days of the episode.'

Treatment targets: depressive cognitions, behavioral activation, anxiety management, shame reduction, safety monitoring. Document diagnostic reasoning explicitly, linking each conclusion to supporting criteria and data sources.

SECTION 7

Strengths and Limitations of Current Taxonomies

While the DSM-5-TR and ICD-11 represent the most sophisticated diagnostic classification systems in the history of mental health, they are not without significant limitations. A balanced understanding of both their strengths and their shortcomings is essential for clinicians who aspire to practice competently and ethically, and is a frequent topic on the EPPP.

Strengths and limitations of current diagnostic classification systems

Strengths	Limitations
Improved reliability: Operationalized criteria significantly improve inter-rater reliability compared to pre-DSM-III approaches.	Validity concerns: Diagnostic categories may not map onto distinct neurobiological entities; the same underlying pathology may present as different DSM disorders.
Common language: Provides a shared vocabulary for clinicians, researchers, insurers, and legal systems.	Comorbidity artifacts: High comorbidity rates may reflect overlapping criteria rather than true co-occurrence of distinct conditions.
Treatment guidance: Diagnoses link to evidence-based treatment protocols and clinical practice guidelines.	Cultural bias: Despite improvements, categories remain rooted in Western psychiatric traditions and may pathologize culturally normative behaviors or miss culture-specific syndromes.
Research facilitation: Standardized criteria enable systematic research and comparability across studies worldwide.	Reification risk: Clinicians may treat diagnostic categories as real entities rather than useful constructs, losing sight of the individual's unique experience.
Administrative utility: Enables insurance reimbursement, disability determinations, and legal proceedings.	Labeling effects: Diagnostic labels can contribute to stigma, affect self-concept, and create self-fulfilling prophecies (Rosenhan, 1973).

✦ KEY TAKEAWAY

Diagnostic taxonomies are like maps — extraordinarily useful for navigation but never perfectly representing the territory they describe. A map of a city accurately captures street layouts and major landmarks but cannot convey the lived experience of walking those streets. Similarly, a DSM-5-TR diagnosis captures critical features of a person's distress in a standardized, communicable format, but it necessarily simplifies and categorizes what is, in reality, a complex, dimensional, and deeply personal experience. The skilled clinician uses the map while remaining aware of its limitations.

SECTION 8

Connections to Emerging Diagnostic Frameworks

The limitations of current taxonomies have spurred the development of alternative and complementary diagnostic frameworks that aspire to greater neurobiological validity. While the DSM-5-TR and ICD-11 remain the operational standards for clinical practice, emerging models are increasingly influencing research agendas and may eventually reshape clinical diagnosis.

Traditional vs. emerging diagnostic frameworks

Feature	Traditional Taxonomies (DSM/ICD)	Emerging Models (RDoC, HiTOP, AMPD)
Classification Approach	Categorical (present vs. absent)	Dimensional (continua of functioning)
Organizing Principle	Syndromal symptom clusters	Neurocircuitry (RDoC), factor-analytic spectra (HiTOP), trait domains (AMPD)
Primary Aim	Clinical communication, treatment planning, and billing	Research on etiology, transdiagnostic mechanisms, and precision treatment
Current Clinical Use	Standard of practice	Research frameworks; AMPD in DSM-5-TR Section III as alternative model
Handling of Comorbidity	Multiple diagnoses assigned	Higher-order dimensions explain shared variance (e.g., "internalizing spectra")

Three emerging frameworks deserve particular attention for EPPP preparation. The Research Domain Criteria (RDoC), developed by the National Institute of Mental Health, organizes psychopathology around six domains of functioning (negative valence, positive valence, cognitive systems, social processes, arousal/regulatory systems, and sensorimotor systems) analyzed across seven units of analysis from genes to self-report. The Hierarchical Taxonomy of Psychopathology (HiTOP) uses factor-analytic methods to organize psychopathology into a hierarchical structure ranging from broad spectra (internalizing, externalizing, thought disorder) to narrow symptom components. The Alternative Model for Personality Disorders (AMPD) in DSM-5-TR Section III represents a bridge between categorical and dimensional approaches, assessing personality pathology through Criterion A (level of personality functioning) and Criterion B (pathological personality traits across five domains). While none of these models has replaced the DSM or ICD for clinical practice, they are shaping the trajectory of the field and may appear on the EPPP as examples of how the science of classification continues to evolve.

SECTION 9

Practice Problems

PROBLEM 1 — CONCEPTUAL

A clinician is evaluating a 35-year-old man who presents with two weeks of depressed mood, insomnia, fatigue, and difficulty concentrating. The client's thyroid-stimulating hormone (TSH) level is significantly elevated. What should the clinician's next step in the diagnostic formulation process be, and why?

PROBLEM 2 — BASIC APPLICATION

A client endorses the following symptoms present for the past month: persistent worry about multiple topics, restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbance. She reports these symptoms cause significant distress and impair her social and occupational functioning. Using DSM-5-TR criteria, what diagnosis would you assign, and which specific criteria are met?

PROBLEM 3 — INTERMEDIATE

A 22-year-old college student presents with three months of depressed mood, anhedonia, hypersomnia, increased appetite with 15-pound weight gain, and psychomotor retardation. She also reports a one-week episode two months ago during which she experienced elevated mood, decreased need for sleep (3 hours/night), rapid speech, and impulsive spending. How does the presence of this one-week episode change the diagnostic formulation, and what is the most appropriate diagnosis?

PROBLEM 4 — APPLIED

A psychologist is conducting a forensic evaluation of a 40-year-old man referred by the court. The client meets DSM-5-TR criteria for both Antisocial Personality Disorder and Alcohol Use Disorder, Severe. During periods of heavy drinking, his antisocial behaviors (violence, property destruction) escalate significantly, but he also has a documented pattern of conduct disorder before age 15 and ongoing deceitfulness and impulsivity during sober periods. How should the psychologist approach the question of comorbidity versus substance-induced behavior in the diagnostic formulation?

PROBLEM 5 — CRITICAL THINKING

A colleague argues that the DSM-5-TR's categorical approach to diagnosis should be entirely replaced by dimensional models such as HiTOP or RDoC because these newer frameworks have greater construct validity. How would you evaluate this argument, considering the purposes that diagnostic classification systems serve in clinical practice, research, and healthcare policy? What would be gained and what would be lost in such a transition?

SUMMARY

Summary: Diagnostic Formulation Using Current Taxonomies

Diagnostic formulation is the systematic process of translating clinical data into accurate, reliable diagnoses using current taxonomies — principally the DSM-5-TR and ICD-11. The process requires criterion-based reasoning (matching symptoms to operationalized criteria), rigorous differential diagnosis using hierarchical exclusion (rule out substance and medical causes first, then distinguish among primary disorders), cultural formulation to contextualize symptoms within the client's cultural framework, and appropriate assignment of severity specifiers and dimensional measures to capture clinical nuance. As an applied competency assessed on the EPPP Part 2, diagnostic formulation also requires the clinician to document reasoning transparently, defend diagnostic conclusions by citing specific criteria and data sources, and integrate findings directly into treatment planning.

While the DSM-5-TR uses polythetic criteria sets and the ICD-11 uses Clinical Descriptions and Diagnostic Requirements (CDDR), both systems provide structured frameworks for reliable diagnosis. Emerging models such as RDoC, HiTOP, and the Alternative Model for Personality Disorders (AMPD) represent the field's movement toward greater dimensional and neurobiologically informed classification, though categorical diagnosis remains the clinical and administrative standard. Competent diagnostic formulation demands integrating data from multiple sources, applying clinical judgment with awareness of both the power and the limitations of current taxonomies, and maintaining cultural humility throughout the process.